ROBINSON JAMES GEORGE purchased 0.3% of their position (10K shares) of NYMOX PHARMACEUTICAL CORP on the open market
Open‑market purchase worth $15.6K — a small addition. The strongest form of insider conviction signal.
Common Stock
Shares
+1K
Price / share
$1.52
Trade value
$1.52K
% of position
Common Stock
Shares
+400.00
Price / share
$1.53
Trade value
$611.20
% of position
Common Stock
Shares
+1.10K
Price / share
$1.53
Trade value
$1.68K
% of position
Common Stock
Shares
+799.00
Price / share
$1.54
Trade value
$1.23K
% of position
Common Stock
Shares
+800.00
Price / share
$1.55
Trade value
$1.24K
% of position
Common Stock
Shares
+600.00
Price / share
$1.56
Trade value
$936.00
% of position
Common Stock
Shares
+100.00
Price / share
$1.58
Trade value
$158.00
% of position
Common Stock
Shares
+5.20K
Price / share
$1.59
Trade value
$8.27K
% of position
Net shares
+10K
Net value
$15.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/6/2019 | P · Purchase | +1K | $1.52 | $1.52K | 0.0% | 3.37M | 3.37M |
| Common Stock Direct | 6/6/2019 | P · Purchase | +400.00 | $1.53 | $611.20 | 0.0% | 3.37M | 3.37M |
| Common Stock Direct | 6/6/2019 | P · Purchase | +1.10K | $1.53 | $1.68K | 0.0% | 3.37M | 3.38M |
| Common Stock Direct | 6/6/2019 | P · Purchase | +799.00 | $1.54 | $1.23K | 0.0% | 3.38M | 3.38M |
| Common Stock Direct | 6/6/2019 | P · Purchase | +800.00 | $1.55 | $1.24K | 0.0% | 3.38M | 3.38M |
| Common Stock Direct | 6/6/2019 | P · Purchase | +600.00 | $1.56 | $936.00 | 0.0% | 3.38M | 3.38M |
| Common Stock Direct | 6/6/2019 | P · Purchase | +100.00 | $1.58 | $158.00 | 0.0% | 3.38M | 3.38M |
| Common Stock Direct | 6/6/2019 | P · Purchase | +5.20K | $1.59 | $8.27K | 0.2% | 3.38M | 3.38M |
| Total | +10K | $15.65K | ||||||